TCT-211: The SYNTAX Trial at 3 Years: A Global Risk Approach to Identify Patients With 3-Vessel &/or Left Main Stem Disease Who Could Safely & Efficaciously Be Treated With Percutaneous Coronary Intervention Part 2: The All-Comers SYNTAX Population

• Book ID: 119270994
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 178 KB
• Volume: 58
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/j.jacc.2011.10.215